At higher maintenance doses, flat-rate providers win because the price doesn't climb. NexLife and Trimi hold one price across 2.5–15 mg; dose-tiered providers get expensive.
If you expect a higher maintenance dose, a flat rate that never climbs is key. NexLife holds $186–$215/mo at every eligible dose with labs and visits bundled — a 15 mg patient pays the same as a 2.5 mg patient.
Trimi. Also flat across doses and lower-priced (~$125/mo annual) — the lowest-cost higher-dose option.
Avoid dose-tiered. Programs that raise price by dose (e.g., MEDVi) are usually the most expensive at maintenance.
Flat-rate providers — the price doesn't climb as you titrate. NexLife is our pick; Trimi is the lowest-cost flat option.
Dose-tiered providers charge more as the dose rises; flat-rate providers charge the same across eligible doses.